4-Methoxybenzoic acid

CAS No. 100-09-4

4-Methoxybenzoic acid ( p-Anisic acid; NSC 32742 )

Catalog No. M17742 CAS No. 100-09-4

4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 41 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Methoxybenzoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.
  • Description
    p-Anisic acid, also known as 4-methoxybenzoic acid or draconic acid, is one of the isomers of anisic acid. The term "anisic acid" often refers to this form specifically. p-Anisic acid is found naturally in anise.
  • Synonyms
    p-Anisic acid; NSC 32742
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100-09-4
  • Formula Weight
    152.14
  • Molecular Formula
    C8H8O3
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    COC1=CC=C(C=C1)C(=O)O
  • Chemical Name
    Benzoic acid, 4-methoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AT-7519 trifluoroace...

    A potent CDK2 inhibitor with IC50 of 47 nM; also inhibits CDK1/4/5 with IC50 of 190/67/18 nM and shows selectivity over some kinases (Aurora A, IR kinase, MEK, PDK1, c-Abl, IC50>10 uM).

  • BMS-509744

    BMS-509744 is a potent, selective and ATP competitive Itk inhibitor with an IC50 of 19 nM.

  • TCS 1102

    TCS 1102 is an effective, dual orexin receptor antagonist (Ki: 0.2/3 nM for OX2/1 receptors).